HomeComparePMXSF vs VICI

PMXSF vs VICI: Dividend Comparison 2026

PMXSF yields 7692.31% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PMXSF wins by $4177739098279588.00M in total portfolio value
10 years
PMXSF
PMXSF
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full PMXSF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — PMXSF vs VICI

📍 PMXSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMXSFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMXSF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMXSF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMXSF
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, PMXSF beats the other by $3,462,531,039,300,622,500,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMXSF + VICI for your $10,000?

PMXSF: 50%VICI: 50%
100% VICI50/50100% PMXSF
Portfolio after 10yr
$2088869549139795.00M
Annual income
$2,036,782,964,294,484,500,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

PMXSF
No analyst data
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMXSF buys
0
VICI buys
0
No recent congressional trades found for PMXSF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMXSFVICI
Forward yield7692.31%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$4177739098279589.00M$988.8K
Annual income after 10y$4,073,565,928,588,968,500,000.00$623,261.32
Total dividends collected$4170772265337663.00M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PMXSF vs VICI ($10,000, DRIP)

YearPMXSF PortfolioPMXSF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$779,931$769,230.77$11,368$948.43+$768.6KPMXSF
2$56,904,315$56,069,789.30$13,339$1,493.16+$56.89MPMXSF
3$3,884,151,673$3,823,264,055.84$16,326$2,426.21+$3884.14MPMXSF
4$248,050,254,929$243,894,212,638.74$21,123$4,112.15+$248050.23MPMXSF
5$14,822,056,221,428$14,556,642,448,653.80$29,379$7,368.23+$14822056.19MPMXSF
6$828,776,618,419,079$812,917,018,262,150.50$44,804$14,191.64+$828776618.37MPMXSF
7$43,367,472,132,823,630$42,480,681,151,115,220.00$76,658$29,972.12+$43367472132.75MPMXSF
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$150,894$71,015.81+$2123871047251.44MPMXSF
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$350,814$193,582.47+$97358102514597.97MPMXSF
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$988,809$623,261.32+$4177739098279588.00MPMXSF

PMXSF vs VICI: Complete Analysis 2026

PMXSFStock

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.

Full PMXSF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this PMXSF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMXSF vs SCHDPMXSF vs JEPIPMXSF vs OPMXSF vs KOPMXSF vs MAINPMXSF vs NNNPMXSF vs EPRTPMXSF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.